Proteomics International Develops Process to ID Venom Peptides for Drug Development

The company claims that its process, which links mass spectrometry with proprietary algorithms, can recover up to five times as many potential peptide drug candidates as has been previously achievable.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.